This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Nov;12(4):113.

doi: 10.1136/ebmh.12.4.113.

Review: rivastigmine reduces rate of cognitive decline and improves performance in mild to moderate Alzheimer's

João Carlos Machado¹

Affiliations

PMID: 19854775
DOI: 10.1136/ebmh.12.4.113

Comment

Review: rivastigmine reduces rate of cognitive decline and improves performance in mild to moderate Alzheimer's

João Carlos Machado. Evid Based Ment Health. 2009 Nov.

. 2009 Nov;12(4):113.

doi: 10.1136/ebmh.12.4.113.

Author

João Carlos Machado¹

Affiliation

¹ Aurus IEPE-Institute of Research and Education on Ageing, Faculdade de Ciências Médicas de Minas Gerais, Belo Horizonte, Brazil.

PMID: 19854775
DOI: 10.1136/ebmh.12.4.113

No abstract available

PubMed Disclaimer

Comment on

Rivastigmine for Alzheimer's disease.
Birks J, Grimley Evans J, Iakovidou V, Tsolaki M. Birks J, et al. Cochrane Database Syst Rev. 2000;(4):CD001191. doi: 10.1002/14651858.CD001191. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2009 Apr 15;(2):CD001191. doi: 10.1002/14651858.CD001191.pub2. PMID: 11034705 Updated.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.